C141H155F5N24O19 — CID 157086492
6-[2-(1-acetylpiperidin-4-yl)oxy-4-pyridinyl]-1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R,4R)-4-hydroxy-2-methylpiperidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methyl-6-[2-(oxan-4-yloxy)-4-pyridinyl]indazol-3-one (PubChem CID 157086492) has the molecular formula C141H155F5N24O19 and a molecular weight of 2584.93 g/mol. Its IUPAC name is 6-[2-(1-acetylpiperidin-4-yl)oxy-4-pyridinyl]-1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R,4R)-4-hydroxy-2-methylpiperidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methyl-6-[2-(oxan-4-yloxy)-4-pyridinyl]indazol-3-one.
| Compound Name | 6-[2-(1-acetylpiperidin-4-yl)oxy-4-pyridinyl]-1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R,4R)-4-hydroxy-2-methylpiperidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methyl-6-[2-(oxan-4-yloxy)-4-pyridinyl]indazol-3-one |
|---|---|
| PubChem CID | 157086492 |
| Molecular Formula | C141H155F5N24O19 |
| Molecular Weight | 2584.93 g/mol |
| Exact Mass | 2583.18 |
| IUPAC Name | 6-[2-(1-acetylpiperidin-4-yl)oxy-4-pyridinyl]-1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R)-4-(2-hydroxyacetyl)-2-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(3R)-4-(2-hydroxyacetyl)-3-methylpiperazin-1-yl]-4-methylpyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-6-[2-[(2R,4R)-4-hydroxy-2-methylpiperidin-1-yl]pyrimidin-5-yl]-2-methylindazol-3-one;1-[[2-(1-fluoroethoxy)phenyl]methyl]-2-methyl-6-[2-(oxan-4-yloxy)-4-pyridinyl]indazol-3-one |
| SMILES | CC(=O)N1CCC(Oc2cc(-c3ccc4c(=O)n(C)n(Cc5ccccc5OC(C)F)c4c3)ccn2)CC1.CC(F)Oc1ccccc1Cn1c2cc(-c3ccnc(OC4CCOCC4)c3)ccc2c(=O)n1C.CC(F)Oc1ccccc1Cn1c2cc(-c3cnc(N4CC[C@@H](O)C[C@H]4C)nc3)ccc2c(=O)n1C.Cc1nc(N2CCN(C(=O)CO)C[C@H]2C)ncc1-c1ccc2c(=O)n(C)n(Cc3ccccc3OC(C)F)c2c1.Cc1nc(N2CCN(C(=O)CO)[C@H](C)C2)ncc1-c1ccc2c(=O)n(C)n(Cc3ccccc3OC(C)F)c2c1 |
| InChI | InChI=1S/2C29H33FN6O4.C29H31FN4O4.C27H30FN5O3.C27H28FN3O4/c1-18-15-34(11-12-35(18)27(38)17-37)29-31-14-24(19(2)32-29)21-9-10-23-25(13-21)36(33(4)28(23)39)16-22-7-5-6-8-26(22)40-20(3)30;1-18-15-34(27(38)17-37)11-12-35(18)29-31-14-24(19(2)32-29)21-9-10-23-25(13-21)36(33(4)28(23)39)16-22-7-5-6-8-26(22)40-20(3)30;1-19(30)37-27-7-5-4-6-23(27)18-34-26-16-21(8-9-25(26)29(36)32(34)3)22-10-13-31-28(17-22)38-24-11-14-33(15-12-24)20(2)35;1-17-12-22(34)10-11-32(17)27-29-14-21(15-30-27)19-8-9-23-24(13-19)33(31(3)26(23)35)16-20-6-4-5-7-25(20)36-18(2)28;1-18(28)34-25-6-4-3-5-21(25)17-31-24-15-19(7-8-23(24)27(32)30(31)2)20-9-12-29-26(16-20)35-22-10-13-33-14-11-22/h2*5-10,13-14,18,20,37H,11-12,15-17H2,1-4H3;4-10,13,16-17,19,24H,11-12,14-15,18H2,1-3H3;4-9,13-15,17-18,22,34H,10-12,16H2,1-3H3;3-9,12,15-16,18,22H,10-11,13-14,17H2,1-2H3/t2*18-,20?;;17-,18?,22-;/m11.1./s1 |
| InChIKey | AEDMFSCDCSOPME-ZVKVSMBCSA-N |
| XLogP | 18.88 |
| TPSA | 442.95 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 189 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2584.93 |
| LogP ≤ 5 | 18.88 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 40 |